Diaphragm sniff ultrasound: Normal values, relationship with sniff nasal pressure and accuracy for predicting respiratory involvement in patients with neuromuscular disorders.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
18
09
2018
accepted:
11
03
2019
entrez:
25
4
2019
pubmed:
25
4
2019
medline:
19
12
2019
Statut:
epublish
Résumé
In patients with neuromuscular disorders, assessment of respiratory function relies on forced vital capacity (FVC) measurements. Providing complementary respiratory outcomes may be useful for clinical trials. Diaphragm sniff ultrasound (US) is a noninvasive technique that can assess diaphragm function that may be affected in patients with neuromuscular disorders. We aimed to provide normal values of sniff diaphragm ultrasound, to assess the relationship between sniff diaphragm US, vital capacity (VC) and sniff nasal pressure. Additionally, we aimed to evaluate the diagnostic accuracy of sniff diaphragm US for predicting restrictive pulmonary insufficiency. We included patients with neuromuscular disorders that had been tested with a sniff diaphragm US and functional respiratory tests. Healthy subjects were also included to obtain normal diaphragm sniff ultrasound. We performed diaphragm tissue Doppler imaging (TDI) and time movement (TM) diaphragm echography combined with sniff maneuver. A total of 89 patients with neuromuscular diseases and 27 healthy subjects were included in our study. In patients, the median age was 32 years [25; 50] and the median FVC was 34% of predicted [18; 55]. Sniff diaphragm motion using TM ultrasound was significantly associated with sniff nasal pressure, both for the right hemidiaphragm (r = 0.6 p <0.0001) and the left hemidiaphragm (r = 0.63 p = 0.0008). Right sniff peak TDI velocity was also significantly associated with FVC (r = 0.72, p<0.0001) and with sniff nasal pressure (r = 0.66 p<0.0001). Sniff diaphragm ultrasound using either TM mode or TDI displayed significant accuracy for predicting FVC<60% with an area under curve (AUC) reaching 0.93 (p<0.0001) for the right sniff diaphragm ultrasound in TM mode and 0.86 (p<0.001) for right peak diaphragm TDI velocity. Sniff diaphragm TM and TDI measures were significantly associated with sniff nasal pressure. Sniff diaphragm TM and TDI had a high level of accuracy to reveal respiratory involvement in patients with neuromuscular disorders. This technique is useful to assess and follow up diaphragm function in patients with neuromuscular disorders. It may be used as a respiratory outcome for clinical trials.
Sections du résumé
BACKGROUND
In patients with neuromuscular disorders, assessment of respiratory function relies on forced vital capacity (FVC) measurements. Providing complementary respiratory outcomes may be useful for clinical trials. Diaphragm sniff ultrasound (US) is a noninvasive technique that can assess diaphragm function that may be affected in patients with neuromuscular disorders.
PURPOSE
We aimed to provide normal values of sniff diaphragm ultrasound, to assess the relationship between sniff diaphragm US, vital capacity (VC) and sniff nasal pressure. Additionally, we aimed to evaluate the diagnostic accuracy of sniff diaphragm US for predicting restrictive pulmonary insufficiency.
MATERIALS AND METHODS
We included patients with neuromuscular disorders that had been tested with a sniff diaphragm US and functional respiratory tests. Healthy subjects were also included to obtain normal diaphragm sniff ultrasound. We performed diaphragm tissue Doppler imaging (TDI) and time movement (TM) diaphragm echography combined with sniff maneuver.
RESULTS
A total of 89 patients with neuromuscular diseases and 27 healthy subjects were included in our study. In patients, the median age was 32 years [25; 50] and the median FVC was 34% of predicted [18; 55]. Sniff diaphragm motion using TM ultrasound was significantly associated with sniff nasal pressure, both for the right hemidiaphragm (r = 0.6 p <0.0001) and the left hemidiaphragm (r = 0.63 p = 0.0008). Right sniff peak TDI velocity was also significantly associated with FVC (r = 0.72, p<0.0001) and with sniff nasal pressure (r = 0.66 p<0.0001). Sniff diaphragm ultrasound using either TM mode or TDI displayed significant accuracy for predicting FVC<60% with an area under curve (AUC) reaching 0.93 (p<0.0001) for the right sniff diaphragm ultrasound in TM mode and 0.86 (p<0.001) for right peak diaphragm TDI velocity.
CONCLUSION
Sniff diaphragm TM and TDI measures were significantly associated with sniff nasal pressure. Sniff diaphragm TM and TDI had a high level of accuracy to reveal respiratory involvement in patients with neuromuscular disorders. This technique is useful to assess and follow up diaphragm function in patients with neuromuscular disorders. It may be used as a respiratory outcome for clinical trials.
Identifiants
pubmed: 31017911
doi: 10.1371/journal.pone.0214288
pii: PONE-D-18-27227
pmc: PMC6481788
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0214288Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Breathe (Sheff). 2016 Dec;12(4):318-327
pubmed: 28210319
Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1678-83
pubmed: 7952632
Am Rev Respir Dis. 1971 May;103(5):641-50
pubmed: 5579907
J Crit Care. 2016 Aug;34:56-65
pubmed: 27288611
Thorax. 1984 Jul;39(7):535-8
pubmed: 6463933
Cardiopulm Phys Ther J. 2018 Oct;29(4):166-172
pubmed: 30319315
Am J Respir Crit Care Med. 2002 Aug 15;166(4):518-624
pubmed: 12186831
Neurocrit Care. 2004;1(4):475-8
pubmed: 16174953
Eur Respir J. 2010 Dec;36(6):1496-8
pubmed: 21119213
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
Am Rev Respir Dis. 1989 Mar;139(3):641-6
pubmed: 2923363
Respiration. 2018;96(3):259-266
pubmed: 30114702
Muscle Nerve. 2013 Jun;47(6):884-9
pubmed: 23625789
PLoS One. 2017 Jun 8;12(6):e0177318
pubmed: 28594857
Respir Care. 2015 Apr;60(4):533-9
pubmed: 25587161
Muscle Nerve. 2013 Mar;47(3):319-29
pubmed: 23382111
Thorax. 1980 Aug;35(8):603-10
pubmed: 7444828
Am J Med. 1987 Oct;83(4):673-80
pubmed: 3674055
Can J Anaesth. 2016 Oct;63(10):1199-200
pubmed: 27324892
Eur Respir J. 2009 Jan;33(1):113-7
pubmed: 18799509
Laryngoscope. 1983 Jan;93(1):49-55
pubmed: 6823174
Heart Fail Rev. 2016 Jan;21(1):77-94
pubmed: 26712329
Thorax. 1983 Aug;38(8):616-23
pubmed: 6412385
Clin Physiol Funct Imaging. 2019 Mar;39(2):143-149
pubmed: 30325572
J Appl Physiol (1985). 1985 May;58(5):1469-76
pubmed: 3158636
Am Rev Respir Dis. 1969 May;99(5):696-702
pubmed: 5772056
Chest. 2009 Feb;135(2):391-400
pubmed: 19017880
Eur Respir J Suppl. 1993 Mar;16:5-40
pubmed: 8499054
Circulation. 2000 Oct 10;102(15):1788-94
pubmed: 11023933
J Thorac Cardiovasc Surg. 2013 Mar;145(3):819-23
pubmed: 22938776